Researchers from The University of Osaka identify a molecule that can support specific therapeutic targeting of AML with ...

Research by Rutgers University-New Brunswick scientists centers on RNA, a nucleic acid that plays a crucial role in most ...

Artiva Biotherapeutics, Inc.’s ARTV share price has surged by 32.38%, which has investors questioning if this is right time ...

Several studies have been conducted, but questions remain about where such therapies will fit into multiple myeloma treatment ...

If preclinical findings were translated into clinic, they could shorten CAR-T generation lead time to one day.

A phase 3 trial of nemvaleukin alfa in with Keytruda for patients with platinum-resistant ovarian cancer will not continue on ...

One main goal of anti-cancer therapies is to kill tumor cells without affecting the surrounding normal cells. Therefore, many ...

The following is a summary of “Retinoid X receptor γ predicts the prognosis and is associated with immune infiltration in ...

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused clinical-stage biopharmaceutical company, today announced its collaboration with Washington University School of Medicine in St. Louis to ...

GRI Bio bolsters IP portfolio with granting of two global patents for Europe & Japan: La Jolla, California Wednesday, April 2, 2025, 14:00 Hrs [IST] GRI Bio, Inc., a biotechnology ...

The Jones Healthcare and Technology Innovation Conference is recognized for bringing together a select group of innovative companies and institutional investors for a two-day event. The event will be ...

Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science ...